Location History:
- Costa Mesa, CA (US) (1998 - 2003)
- Irvine, CA (US) (2000 - 2010)
Company Filing History:
Years Active: 1998-2010
Title: Robert C Tam: A Pioneer in Anti-Neoplastic and Immune Modulation Innovations
Introduction
Robert C Tam, based in Costa Mesa, California, is a distinguished inventor with an impressive portfolio of 21 patents. His work primarily focuses on the development of pharmaceutical compounds that address critical health challenges, particularly in cancer treatment and immune system modulation.
Latest Patents
Among his notable inventions are two groundbreaking patents. The first, titled "Phenylamino Isothiazole Carboxamidines as MEK Inhibitors," introduces compounds that inhibit MEK activity, which are essential as anti-neoplastic agents. These innovative compounds include N-substituted-3-hydroxy-5-arylamino-isothiazole-4-carboxamidines and various tautomeric isothiazol-3(2H)-ones.
The second patent, "Nucleoside Analogs with Carboxamidine Modified Monocyclic Base," discloses novel nucleoside analog compounds. These compounds, along with their pharmaceutically acceptable esters or salts, are poised to transform treatments for infections, infestations, neoplasms, and autoimmune diseases. Additionally, these compounds offer the potential to modulate various aspects of the immune system, influencing both Type 1 and Type 2 immune responses.
Career Highlights
Throughout his career, Robert has made significant contributions to pharmaceutical research and development. He has notably worked with ICN Pharmaceuticals, Inc., where he furthered his innovative research in the pharmaceutical field. His dedication to high-impact inventions continues to pave the way for advancements in medical treatments.
Collaborations
Robert's journey in the realm of invention has seen fruitful collaborations with esteemed colleagues, including Devron R Averett and Kandasamy Ramasamy. These partnerships highlight the synergy essential for pioneering innovative solutions in health care.
Conclusion
Robert C Tam stands out as an influential inventor in the pharmaceutical industry, particularly known for his advancements in anti-neoplastic agents and immune modulation. His ongoing commitment to innovation is reflected in his patented inventions that aim to improve health outcomes and offer new therapeutic options. As he continues to explore new avenues of research, the impact of his work is expected to resonate in the field of medicine for years to come.